Share This Author
Adherence with colorectal cancer screening guidelines: a review.
Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India.
- S. Subramanian, R. Sankaranarayanan, K. Ramadas
- MedicineBulletin of the World Health Organization
- 1 March 2009
The most cost-effective approach to oral cancer screening by visual inspection is to offer it to the high-risk population, and targeted screening of this group will ensure that screening can be offered at a reasonable cost in a limited-resource setting.
Oral Cancer: Prevention, Early Detection, and Treatment
This chapter discusses the epidemiology, prevention, early detection, and treatment of oral cancers, as well as the cost-effectiveness of interventions.
Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview Survey
- S. Subramanian, M. Amonkar, T. Hunt
- MedicineCancer Epidemiology Biomarkers & Prevention
- 1 February 2005
B baseline values are provided that can be used to project future colonoscopy demand and identify potential supply barriers and the elderly, non-White males and those with private insurance have a higher probability of receiving Colonoscopy than FOBT.
Costs Associated with Developing and Implementing a Computerized Clinical Decision Support System for Medication Dosing for Patients with Renal Insufﬁciency in the Long-term Care Setting
A team of physicians, pharmacists, and informatics professionals developed a CDSS added to a commercial electronic medical record system to provide prescribers with patient-speciﬁc maximum dosing…
The Costs Associated With Adverse Drug Events Among Older Adults in the Ambulatory Setting
- T. Field, B. Gilman, S. Subramanian, Jackie C Fuller, D. Bates, J. Gurwitz
- MedicineMedical care
- 1 December 2005
Adverse drug events in the ambulatory setting substantially increase the healthcare costs of elderly persons, and based on rates of adverse drug events and these cost estimates, 1000 older adults would have annual costs related to adverse drug Events in the ambulance setting of $65,631.
Outcome and Resource Use Associated With Myomectomy
Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors
There is substantial variation in patient costs between the public and private sectors in Kenya, and most NCD diagnosis and treatment costs, even in the public sector, represent a substantial economic burden that can result in catastrophic expenditures.
Computerized Physician Order Entry with Clinical Decision Support in Long‐Term Care Facilities: Costs and Benefits to Stakeholders
- S. Subramanian, S. Hoover, B. Gilman, T. Field, R. Mutter, J. Gurwitz
- Medicine, Political ScienceJournal of the American Geriatrics Society
- 1 September 2007
The analysis suggests that multiple stakeholders will incur the costs related to implementation of CPOE with CDS in the LTC setting, but the costs incurred by each may not be aligned with the benefits, which may present a major barrier to broad adoption.
Symptoms, Diagnoses, and Time to Key Diagnostic Procedures Among Older U.S. Women With Ovarian Cancer
Women with ovarian cancer presenting with gastrointestinal symptoms were more likely to have later-stage disease and longer time to key diagnostic tests than those with gynecologic symptoms.